Are you a newbie to Australia. Click here to know more about Studying in Australia, About living here, getting your first job and planning for Permanent residency.
Guide to OZ Jobs/Rooms listingsAstraZeneca Plc said on Monday it has begun enrolling adults for a US-funded, 30,000-subject late-stage study of its high profile COVID-19 vaccine candidate. Trial participants will receive either two doses of the experimental vaccine, dubbed AZD1222, four weeks apart, or a placebo, the company said. The trial is being conducted under U.S. governm...
AstraZeneca said on Tuesday it had begun testing an antibody-based treatment for the prevention and treatment of COVID-19, with the first participants dosed, adding to recent signs of progress on possible medical solutions to the disease. The British drugmaker, whose COVID-19 vaccine candidate is already among the most advanced, said the early-sta...
MEXICO CITY: Mexico will need up to 200 million coronavirus vaccine doses, according to a senior government official, and inoculation of its 120 million inhabitants could start as early as April if clinical trials and regulatory approvals for pharmaceutical firm AstraZeneca Plc go as planned. In partnership with the governments of Mexico and Argent...
Q2 profit and sales beat on portfolio strength Reiterates 2020 guidance for what has been a strong year Optimism around AZ/Oxford coronavirus vaccine high Shares rise as much as 3% in morning trade Britain’s AstraZeneca bettered second-quarter sales and profit estimates on Thursday, thanks to strong sales during the lockdowns from the drugm...
AstraZeneca will pay $1 billion upfront Firms’ second oncology deal to look into breast and lung cancers AZN also gets regulatory backing for two other cancer drugs Britain’s AstraZeneca will pay up to $6 billion to Japan’s Daiichi Sankyo under the drugmakers’ second multi-billion dollar oncology collaboration to develop ...
LONDON: The University of Oxford’s possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty, the lead developer of the vaccine said on Tuesday. The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday...
LONDON: Britain’s Prince William on Wednesday visited the Oxford-based scientists who are working to develop a viable vaccine for COVID-19 as well as trial participants who are helping to determine whether or not it works. The vaccine, originally known as ChAdOx1 nCoV-19, was originally developed by scientists at the University of Oxford, an...